European Commission approves Bristol Myers Squibb's Sotyktu for psoriatic arthritis

Rznomics receives FDA RMAT designation for HCC candidate RZ‑001

Chance Pharma reports NMPA acceptance of NDA for investigational respiratory drug CXG87

Halozyme and GSK sign global drug‑delivery collaboration

Partner Therapeutics' BIZENGRI receives FDA Commissioner's National Priority Voucher for NRG1 fusion-positive cholangiocarcinoma

Diakonos Oncology's DOC1021 granted US FDA Fast Track Designation for unresectable or metastatic cutaneous melanoma

Racura Oncology identifies mechanism of action for (E,E)-bisantrene

Bayer to acquire Perfuse Therapeutics in USD2.45bn deal to expand ophthalmology pipeline

ZYUS Life Sciences receives second US pain management patent

Citius Oncology to accelerate LYMPHIR commercialisation with up to USD36.5m in debt and equity capital

Lunai Bioworks completes USD20m preferred issuance to acquire CNS delivery and neurotherapeutic IP

Photocure study supports cost-effectiveness of blue light cystoscopy

Apotex receives Health Canada approval for a generic Ozempic equivalent

Spinogenix to present tazbentetol preclinical results in glaucoma and diabetic retinopathy models at ARVO 2026

Specialised Therapeutics' chronic graft-versus-host disease therapy approved in Australia